These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21749142)

  • 1. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.
    Manna SK; Patterson AD; Yang Q; Krausz KW; Idle JR; Fornace AJ; Gonzalez FJ
    J Proteome Res; 2011 Sep; 10(9):4120-33. PubMed ID: 21749142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse.
    Manna SK; Patterson AD; Yang Q; Krausz KW; Li H; Idle JR; Fornace AJ; Gonzalez FJ
    J Proteome Res; 2010 Aug; 9(8):4176-88. PubMed ID: 20540569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model.
    Manna SK; Thompson MD; Gonzalez FJ
    Adv Exp Med Biol; 2015; 815():217-38. PubMed ID: 25427910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
    Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Metabolic Pathways and Metabolites in a C57BL/6J Mouse Model of Alcoholic Liver Disease.
    Ma T; Li Y; Zhu Y; Jiang S; Cheng C; Peng Z; Xu L
    Med Sci Monit; 2020 May; 26():e924602. PubMed ID: 32384076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis.
    Shi X; Yao D; Chen C
    J Biol Chem; 2012 Feb; 287(9):6336-49. PubMed ID: 22228769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury.
    Zhang T; Bao L; Zhao Q; Wu ZE; Dai M; Rao Q; Li F
    J Proteome Res; 2023 Jul; 22(7):2327-2338. PubMed ID: 37232578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography-mass spectrometry untargeted metabolomics reveals increased levels of tryptophan indole metabolites in urine of metabolic syndrome patients.
    Esperanza MG; Wrobel K; Ojeda AG; Garay-Sevilla ME; Escobosa ARC; Barrientos EY; Wrobel K
    Eur J Mass Spectrom (Chichester); 2020 Dec; 26(6):379-387. PubMed ID: 33295818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism.
    Xu R; He L; Vatsalya V; Ma X; Kim S; Mueller EG; Feng W; McClain CJ; Zhang X
    Am J Physiol Gastrointest Liver Physiol; 2023 Feb; 324(2):G142-G154. PubMed ID: 36513601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity.
    Zhang A; Sun H; Wang X
    Sci Rep; 2014 Oct; 4():6768. PubMed ID: 25341677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo.
    Bonzo JA; Patterson AD; Krausz KW; Gonzalez FJ
    Mol Endocrinol; 2010 Dec; 24(12):2343-55. PubMed ID: 20943816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction.
    Zhao LK; Zhao YB; Yu PC; Zhang PX
    Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.
    Li F; Patterson AD; Krausz KW; Tanaka N; Gonzalez FJ
    J Lipid Res; 2012 Aug; 53(8):1625-35. PubMed ID: 22665165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
    Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput metabolomics approach reveals new mechanistic insights for drug response of phenotypes of geniposide towards alcohol-induced liver injury by using liquid chromatography coupled to high resolution mass spectrometry.
    Zhang T; Zhang A; Qiu S; Sun H; Han Y; Guan Y; Wang X
    Mol Biosyst; 2016 Dec; 13(1):73-82. PubMed ID: 27896352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's in Metabolomics for Alcoholic Liver Disease?
    Suciu AM; Crisan DA; Procopet BD; Radu CI; Socaciu C; Tantau MV; Stefanescu HO; Grigorescu M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):51-58. PubMed ID: 29557415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation.
    Patterson AD; Slanar O; Krausz KW; Li F; Höfer CC; Perlík F; Gonzalez FJ; Idle JR
    J Proteome Res; 2009 Sep; 8(9):4293-300. PubMed ID: 19569716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling of copper-laden hepatolenticular degeneration model rats and the interventional effects of Gandou decoction using UPLC-Q-TOF/MS.
    Cheng M; Wu H; Wu H; Liu X; Zhou A
    J Pharm Biomed Anal; 2019 Feb; 164():187-195. PubMed ID: 30390561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of Dahuang-Mudan decoction on TNBS-induced colitis using UPLC-QTOF/MS-based metabolomic analysis.
    Nong F; Luo S; Liang Y; Zhao Z; Xing S; Wen B; Zhou L
    Biomed Chromatogr; 2021 Mar; 35(3):e5003. PubMed ID: 33063880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.